Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia

Leukemia. 2010 Jan;24(1):237-9. doi: 10.1038/leu.2009.205. Epub 2009 Oct 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / therapeutic use*
  • Disease-Free Survival
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin Variable Region / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Mutation
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use
  • ZAP-70 Protein-Tyrosine Kinase / genetics

Substances

  • Antineoplastic Agents
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
  • ZAP-70 Protein-Tyrosine Kinase
  • ZAP70 protein, human
  • Vidarabine
  • fludarabine